Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Clinical and Translational Science|April 29, 2026
From Models to Medicines: A Narrative History and Regulatory Perspective on the Translational Impact of Model-Informed Drug Development (MIDD)Issam ZinehFuture Cardiology|October 7, 2009
HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practiceIssam ZinehHeart Failure Reviews|March 21, 2008
Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure managementAmber L Beitelshees, Issam ZinehBiomarkers in Medicine|November 23, 2011
Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicineIssam Zineh, Shiew-Mei HuangPharmacogenomics|December 15, 2010
Generating and weighing evidence in drug development and regulatory decision making: 5th US FDA-DIA workshop on pharmacogenomicsPeter M Shaw, Issam ZinehExpert Opinion on Pharmacotherapy|July 25, 2006
Pharmacogenetics of chronic cardiovascular drugs: applications and implicationsIssam Zineh, Julie A JohnsonPharmacotherapy|September 20, 2011
Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug AdministrationIssam Zineh, Michael A PacanowskiPharmacogenomics|March 31, 2010
DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDALawrence J Lesko, Issam ZinehClinical Pharmacology and Therapeutics|November 21, 2017
Perspectives on the Current State of the Biosimilar Regulatory Pathway in the United StatesMichele K Dougherty, Issam Zineh, Leah ChristlPageof 11